Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra

被引:47
作者
Jiang, Hong [1 ]
Song, Ning [1 ]
Wang, Jun [1 ]
Ren, Li-Ying [1 ]
Xie, Jun-Xia [1 ]
机构
[1] Qingdao Univ, Coll Med, Dept Physiol, Qingdao 266071, Peoples R China
基金
中国国家自然科学基金;
关键词
iron dextran; dopamine; dopaminergic neuron; substantia nigra; caudate putamen;
D O I
10.1016/j.neuint.2007.03.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron accumulation is considered to be involved in the pathogenesis of Parkinson's disease. To demonstrate the relationship between peripheral iron overload and dopaminergic neuron loss in rat substantia nigra (SN), in the present study we used fast cyclic voltammetry, tyrosine hydroxylase (TH) immunohistochemistry, Perls' iron staining, and high performance liquid chromatography-electrochemical detection to study the degeneration of dopaminergic neurons and increased iron content in the SN of iron dextran overloaded animals. The findings showed that peripheral iron dextran overload increased the iron staining positive cells and reduced the number of TH-immunoreactive neurons in the SN. As a result, dopamine release and content, as well as its metabolites contents were decreased in caudate putamen. Even more dramatic changes were found in chronic overload group. These results suggest that peripheral iron dextran can increase the iron level in the SN, where excessive iron causes the degeneration of dopaminergic neurons. The chronic iron overload may be more destructive to dopaminergic neurons than the acute iron overload. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:32 / 36
页数:5
相关论文
共 32 条
[1]   Prevalence of haemochromatosis gene mutations in Parkinson's disease [J].
Aamodt, Anne Hege ;
Stovner, Lars Jacob ;
Thorstensen, Ketil ;
Lydersen, Stian ;
White, Linda R. ;
Aasly, Jan O. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (03) :315-317
[2]   Disturbance of iron metabolism in Parkinson's disease ultrasonography as a biomarker [J].
Berg, D ;
Hochstrasser, H ;
Schweitzer, KJ ;
Riess, O .
NEUROTOXICITY RESEARCH, 2006, 9 (01) :1-13
[3]   Brain iron pathways and their relevance to Parkinson's disease [J].
Berg, D ;
Gerlach, M ;
Youdim, MBH ;
Double, KL ;
Zecca, L ;
Riederer, P ;
Becker, G .
JOURNAL OF NEUROCHEMISTRY, 2001, 79 (02) :225-236
[4]   Iron accumulation in the substantia nigra in rats visualized by ultrasound [J].
Berg, D ;
Grote, C ;
Rausch, WD ;
Mäurer, M .
ULTRASOUND IN MEDICINE AND BIOLOGY, 1999, 25 (06) :901-904
[5]   Glutathione, iron and Parkinson's disease [J].
Bharath, S ;
Hsu, M ;
Kaur, D ;
Rajagopalan, S ;
Andersen, JK .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (5-6) :1037-1048
[6]  
CONNOR JR, 1995, J NEUROCHEM, V65, P717
[7]   Chronic iron overload enhances inducible nitric oxide synthase expression in rat liver [J].
Cornejo, P ;
Varela, P ;
Videla, LA ;
Fernández, V .
NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2005, 13 (01) :54-61
[8]   Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series [J].
Costello, DJ ;
Walsh, SL ;
Harrington, HJ ;
Walsh, CH .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (04) :631-633
[9]   Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis [J].
Day, SM ;
Duquaine, D ;
Mundada, LV ;
Menon, RG ;
Khan, BV ;
Rajagopalan, S ;
Fay, WP .
CIRCULATION, 2003, 107 (20) :2601-2606
[10]  
Double KL, 1998, J NEUROCHEM, V70, P2492